Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review

BACKGROUND: Patients with autoimmune rheumatic diseases (ARD) are at a potentially higher risk for COVID-19 infection complications. Given their inherent altered immune system and the use of immunomodulatory medications, vaccine immunogenicity could be unpredictable with a suboptimal or even an exag...

Descripción completa

Detalles Bibliográficos
Autores principales: Joudeh, Anwar I., Lutf, Abdu Qaid, Mahdi, Salah, Tran, Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201317/
https://www.ncbi.nlm.nih.gov/pubmed/37244811
http://dx.doi.org/10.1016/j.vaccine.2023.05.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201317/
https://www.ncbi.nlm.nih.gov/pubmed/37244811
http://dx.doi.org/10.1016/j.vaccine.2023.05.048

Ejemplares similares